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Background
When scaling up a monoclonal antibody (mAb) produc-
tion process in stirred tank bioreactor, oxygen transfer is
probably one of the most challenging parameters to con-
sider. Approaches such as keeping constant specific power
input or tip speed across the scales are widely described
in the literature and are often based on the assumption
that mammalian cells are sensitive to shear stress.
However, with the high cell densities reached in modern
processes, such scale-up strategies can lead to relatively
high gas flow rate to compensate low agitation speed
which could be detrimental to cells in its own right.
As an alternative, we explored a scale-up strategy
based on the overall oxygen transfer flux (OTF) required
by the cell culture process. OTF was defined as directly
proportional to oxygen transfer coefficient (kLa) and
oxygen enrichment in the gas mix. This way the overall
gas flow can be kept at relatively low values, while satisfy-
ing the oxygen requirements of a high cell density culture.
Materials and methods
Process scale-up between 3 different stirred tank bioreac-
tors was studied: a 2 L glass bioreactor (Sartorius Stedim
Biotech) equipped with one 3-segment blade impeller, a
10 L glass bioreactor (Sartorius Stedim Biotech) equipped
with two 3-segment blade impellers and a 80 L stainless
steel bioreactor (Zeta Biopharma) equipped with two
elephant ear impellers.
Oxygen transfer coefficients (kLa) were determined for
the chemically defined production medium, using the
dynamic technique of oxygen adsorption. The statistical
analysis software JMP (SAS) was then used in order to
express kLa’s according to the following equation: kLa =
A * (P/V) a * Vsb, P/V being volumetric power input
[W.m-3] and Vs being superficial air velocity [m.s-1], and
to analyze our results.
Oxygen transfer flux was defined as followed: OTF =
kLa * (%O2 in the gas mix/% O2 in air).
For cell culture experiments, bioreactors were inoculated
with a CHO cell line producing a mAb. Cells were culti-
vated in chemically defined media for a 14-day fed-batch
process. The culture was controlled to maintain the
desired process parameters (temperature, pH, dO2 and
glucose concentration). dO2 level was maintained using a
cascade aeration. Viable cell density (VCD) and viability
were monitored by Trypan blue dye exclusion using a
Vicell XR (Beckman Coulter). Glucose and lactate con-
centrations were determined using a Nova Bioprofile 400
analyzer (Nova Biomedical). Offline dissolved CO2 and
osmolality were measured with a Nova Bioprofile pHox
(Nova Biomedical) and Osmo 2020 (Advanced Instru-
ment) analyzers respectively. mAb concentrations were
determined by Protein A HPLC.
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Table 1 Determination of aeration and agitation strategy
in the 80 L bioreactor, based on the maximum OTF
required by the cells at 2 L and 10 L scales.
2 L 10 L 80 L
P/V [W.m-3] 30 69 80
Vs [×10-4 m.s-1] 0.94 3.53 4.03
kLa [×10
-3 s-1] 0.70 1.43 3.85
%O2 in gas mix 74 90 30
OTF max [×10-3 s-1] 2.44 6.11 Target OTF for 80 L
= 10 L OTF
®
5.55
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Results
kLa mapping of 2 L, 10 L and 80 L bioreactors
The 2 L and 10 L bioreactors were characterized for a
range of superficial gas velocity going from 5.0 × 10-5
to 4.0 × 10-4 m.s-1 and the 80 L for a range going from
2.0 × 10-4 to 1.2 × 10-3 m.s-1. Specific power input was
ranged from 10 to 90 W.m-3 for the 2 L bioreactor, 20
to 130 W.m-3 for the 10 L bioreactor and 5 to 80 W.m-3
for the 80 L bioreactor. Models were generated with
JMP and gave the following equations for kLa [s
-1]:
2 L bioreactor: kLa = 6.37 × 10
-2 * (P/V)0.28 * Vs0.59
(R2 = 0.98, Prob>F: <0.0001)
10 L bioreactor: kLa = 4.07 × 10
-2 * (P/V)0.55 * Vs0.67
(R2 = 0.91, Prob>F: <0.0001)
80 L bioreactor: kLa = 5.53 × 10
-2 * (P/V)0.72 * Vs0.77
(R2 = 0.92, Prob>F: <0.0001)
Scale-up of aeration and agitation strategy of a
monoclonal antibody production process using a
constant OTF approach
The cell culture process was initially developed at 2 L
and 10 L scale. Maximum Oxygen Transfer Flux was
determined at maximum cell density for these two
scales. This maximum OTF was kept constant for
scaling up to 80 L (Table 1). From kLa mapping of the
80 L bioreactor, appropriate P/V, Vs and O2% values
were chosen in order to reach the target OTF.
To confirm that high specific power input are well
tolerated by CHO cells, the fed-batch process was first
run in two 2 L bioreactors (Figure 1a). Agitation speed
was set at 250 rpm (20 W.m-3) in the first bioreactor
and at 400 rpm (90 W.m-3) in the second bioreactor.
In the high agitation condition, the maximum VCD was
1.8-fold higher, viability remained above 80% (versus
60% in the low agitation condition) and mAb titer
was 2.2-fold higher.
Our model fed-batch process was then run in our
80 L bioreactor, using the aeration strategy defined in
Table 1. Figure 1b, c and 1d show that the process was
successfully scaled-up from 2 L and 10 L to 80 L
bioreactor.
Conclusions
Thanks to extensive characterization of aeration condi-
tions in 2 L, 10 L and 80 L bioreactors, the oxygen
transfer flux approach enabled to have a sufficient aera-
tion and comparable process performance across the
scales, including dCO2 profile. The same strategy will be
Figure 1 Cell culture process performance at 2 L, 10 L and 80 L scale. a) Impact of agitation speed on VCD and mAb titer at 2 L scale. b)
Comparison of VCD, viability and mAb titer obtained in 2 L, 10 L and 80 L bioreactors. c) Comparison of osmolality, glucose and lactate profiles
obtained in 2 L, 10 L and 80 L bioreactor. d) Online pH and dCO2 levels obtained in 2 L, 10 L and 80 L bioreactors.
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used for further scale-up of the process to 2000 L. How-
ever, the results also revealed that our 2 L scale model
should be re-assessed to become more predictive of
10 L and 80 L scales.
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